Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation

Saved in:
Bibliographic Details
Published in:ImmunoTargets and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864030191645360129
collection WordPress RSS
FRELIP Feed Integration
container_title ImmunoTargets and Therapy
description
discipline_display Medical & Health Sciences
discipline_facet Medical & Health Sciences
format Online Article
RSS Article
genre Journal Article
id rss_article:35742
institution FRELIP
journal_source_facet ImmunoTargets and Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
— — — — — Allergology and Immunology
Clinical Medicine
Medical & Health Sciences
sub_discipline_display Clinical Medicine
sub_discipline_facet Clinical Medicine
subject_display — — — — — Allergology and Immunology
Clinical Medicine
Medical & Health Sciences
— — — — — Allergology and Immunology
Clinical Medicine
Medical & Health Sciences
subject_facet — — — — — Allergology and Immunology
Clinical Medicine
Medical & Health Sciences
title Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_auth Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_full Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_fullStr Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_full_unstemmed Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_short Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_sort kasugamycin inhibits melanoma lung metastasis and chi3l1-driven m2-like tumor-associated macrophage differentiation
topic — — — — — Allergology and Immunology
Clinical Medicine
Medical & Health Sciences
url https://www.dovepress.com/kasugamycin-inhibits-melanoma-lung-metastasis-and-chi3l1-driven-m2-lik-peer-reviewed-fulltext-article-ITT